Tilray/$TLRY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tilray
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
Ticker
$TLRY
Sector
Primary listing
Employees
2,842
Headquarters
Leamington, Canada
Website
Tilray Metrics
BasicAdvanced
$1.7B
-
-$2.30
2.13
-
Price and volume
Market cap
$1.7B
Beta
2.13
52-week high
$2.32
52-week low
$0.35
Average daily volume
91M
Financial strength
Current ratio
2.62
Quick ratio
1.39
Long term debt to equity
19.188
Total debt to equity
21.29
Interest coverage (TTM)
-2.31%
Profitability
EBITDA (TTM)
28.871
Gross margin (TTM)
28.86%
Net profit margin (TTM)
-258.54%
Operating margin (TTM)
-10.64%
Effective tax rate (TTM)
5.47%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-1.74%
Return on equity (TTM)
-85.74%
Valuation
Price to revenue (TTM)
1.668
Price to book
1.07
Price to tangible book (TTM)
2.16
Price to free cash flow (TTM)
-14.24
Free cash flow yield (TTM)
-7.02%
Free cash flow per share (TTM)
-0.104
Growth
Revenue change (TTM)
2.31%
Earnings per share change (TTM)
753.77%
3-year revenue growth (CAGR)
10.63%
10-year revenue growth (CAGR)
94.12%
3-year earnings per share growth (CAGR)
32.17%
10-year earnings per share growth (CAGR)
39.70%
What the Analysts think about Tilray
Analyst ratings (Buy, Hold, Sell) for Tilray stock.
Bulls say / Bears say
Tilray’s move into hemp-derived THC seltzers, leveraging its craft beer distribution network, positions it well to compete in the U.S. cannabis beverage market, which is forecast to surpass $1 billion in 2025. (Reuters)
Tilray stock jumped around 20% in premarket trading after President Trump voiced support for CBD, signaling increasing political momentum and a possible loosening of federal cannabis laws. (Reuters)
If cannabis is reclassified as Schedule III at the federal level, Tilray could avoid Section 280E tax costs, saving about $150 million each year and significantly improving profitability. (Reuters)
Oversupply and sharply falling prices have reduced valuations and margins in Tilray’s main cannabis business. Big industry players are now trading at average forward revenue multiples just above 1, and are expected to collectively report losses. (Reuters)
Tilray shares continued to see downward pressure, slipping 1% on September 13, 2025. This weighed on the TSX healthcare sector, which dropped 0.2%, and highlights ongoing investor doubt about Tilray’s core markets. (Reuters)
Major alcohol companies are approaching the cannabis beverage market with caution and are preparing to defend their market share, given regulatory uncertainties. This increases execution risk for Tilray as it launches its hemp-derived seltzer. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Oct 2025.
Tilray Financial Performance
Revenues and expenses
Tilray Earnings Performance
Company profitability
Tilray News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tilray stock?
Tilray (TLRY) has a market cap of $1.7B as of October 25, 2025.
What is the P/E ratio for Tilray stock?
The price to earnings (P/E) ratio for Tilray (TLRY) stock is 0 as of October 25, 2025.
Does Tilray stock pay dividends?
No, Tilray (TLRY) stock does not pay dividends to its shareholders as of October 25, 2025.
When is the next Tilray dividend payment date?
Tilray (TLRY) stock does not pay dividends to its shareholders.
What is the beta indicator for Tilray?
Tilray (TLRY) has a beta rating of 2.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.